Fecal Microbiota Transplant for Inflammatory Bowel Disease
Status:
Completed
Trial end date:
2017-11-04
Target enrollment:
Participant gender:
Summary
Currently enrolling only patients with Ulcerative Colitis. Enrollment and experimental
treatment of patients with Crohn's Disease stopped for a safety evaluation.
This is a prospective, open label pilot study in which patients with symptoms of Inflammatory
bowel disease will receive FMT therapy delivered via colonoscopy.
The investigators hypothesize that FMT is a safe and effective treatment for patients with
inflammatory bowel disease. The aims are:
1. To determine if symptoms of inflammatory bowel disease can be successfully treated by
Fecal Microbial Transplantation.
2. To determine if endoscopic appearance of colon or ileum improves following treatment by
Fecal Microbial Transplantation.